

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Advances in understanding COPD | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-2392/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-2392" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Advances in understanding COPD" />
    
            <meta name="og:title" content="F1000Research Article: Advances in understanding COPD.">
            <meta name="og:description" content="Read the latest article version by Gary P. Anderson, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="7556">
            <meta name="article-id" content="7018">
            <meta name="dc.title" content="Advances in understanding COPD">
            <meta name="dc.description" content="In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments.">
            <meta name="dc.subject" content="Chronic Obstructive Pulmonary Disease, COPD, ACOS, COPD Asthma Overlap Syndrome, Bronchodilators, Myodebilitation, Catabasis, ">
            <meta name="dc.creator" content="Anderson, Gary P.">
            <meta name="dc.date" content="2016/09/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.7018.1">
            <meta name="dc.source" content="F1000Research 2016 5:2392">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Chronic Obstructive Pulmonary Disease ">
            <meta name="prism.keyword" content=" COPD ">
            <meta name="prism.keyword" content=" ACOS ">
            <meta name="prism.keyword" content=" COPD Asthma Overlap Syndrome ">
            <meta name="prism.keyword" content=" Bronchodilators ">
            <meta name="prism.keyword" content=" Myodebilitation ">
            <meta name="prism.keyword" content=" Catabasis ">
            <meta name="prism.keyword" content=" ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/09/27">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="2392">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.7018.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-2392">
            <meta name="citation_title" content="Advances in understanding COPD">
            <meta name="citation_abstract" content="In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments.">
            <meta name="citation_description" content="In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments.">
            <meta name="citation_keywords" content="Chronic Obstructive Pulmonary Disease, COPD, ACOS, COPD Asthma Overlap Syndrome, Bronchodilators, Myodebilitation, Catabasis, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Gary P. Anderson">
            <meta name="citation_author_institution" content="Lung Health Research Centre, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia">
            <meta name="citation_author_institution" content="Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia">
            <meta name="citation_publication_date" content="2016/09/27">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="2392">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.7018.1">
            <meta name="citation_firstpage" content="2392">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-2392/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-2392.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=7556 /> <input type=hidden id=articleId name=articleId value=7018 /> <input type=hidden id=xmlUrl value="/articles/5-2392/v1/xml"/> <input type=hidden id=xmlFileName value="-5-2392-v1.xml"> <input type=hidden id=article_uuid value=9f38b5e3-4ea1-4c6a-bd52-38a11de677df /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Advances in understanding COPD"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.7018.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.7018.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-2392"
  },
  "headline": "Advances in understanding COPD",
  "datePublished": "2016-09-27T15:53:50",
  "dateModified": "2016-09-27T15:53:50",
  "author": [
    {
      "@type": "Person",
      "name": "Gary P. Anderson"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-2392/v1",
            "name": "Advances in understanding COPD"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Advances in understanding COPD </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=7556 data-id=7018 data-downloads="" data-views="" data-scholar="10.12688/f1000research.7018.1" data-recommended="" data-doi="10.12688/f1000research.7018.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-2392/v1/pdf?article_uuid=9f38b5e3-4ea1-4c6a-bd52-38a11de677df" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-7018-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-7018-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-7018-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Anderson GP. Advances in understanding COPD [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2392 (<a class=new-orange href="https://doi.org/10.12688/f1000research.7018.1" target=_blank>https://doi.org/10.12688/f1000research.7018.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-7018-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=7018 id=track-article-signin-7018 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/7018?target=/articles/5-2392/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=7556 /> <input name=articleId type=hidden value=7018 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Advances in understanding COPD</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:gpa@unimelb.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Gary P. Anderson</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:gpa@unimelb.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Gary P. Anderson</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Sep 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.7018.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Lung Health Research Centre, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia<br/> <sup>2</sup> Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=12192-13412></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=1789-13413></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=6406-13411></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Chronic Obstructive Pulmonary Disease, COPD, ACOS, COPD Asthma Overlap Syndrome, Bronchodilators, Myodebilitation, Catabasis, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Gary P. Anderson (<a href="mailto:gpa@unimelb.edu.au">gpa@unimelb.edu.au</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Gary P. Anderson </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author has received advisory board and speaker honoraria from AstraZeneca/MedImmune (Gaithersburg, MD, USA), Boehringer Ingelheim (Ingelheim, Germany), GlaxoSmithKline (Brentford, UK), Janssen (Beerse, Belgium), Mundipharma (Cambridge, UK), and Novartis (Basel, Switzerland). This year, he is undertaking a sabbatical secondment as &ldquo;chief scientist&rdquo; in the AstraZeneca RIA iMED drug discovery division in Cambridge, UK, funded by AstraZeneca. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2016 Anderson GP. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Anderson GP. Advances in understanding COPD [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2392 (<a href="https://doi.org/10.12688/f1000research.7018.1" target=_blank>https://doi.org/10.12688/f1000research.7018.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Sep 2016, <b>5</b>(F1000 Faculty Rev):2392 (<a href="https://doi.org/10.12688/f1000research.7018.1" target=_blank>https://doi.org/10.12688/f1000research.7018.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Sep 2016, <b>5</b>(F1000 Faculty Rev):2392 (<a href="https://doi.org/10.12688/f1000research.7018.1" target=_blank>https://doi.org/10.12688/f1000research.7018.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e149>Introduction</h2><p class="" id=d15775e152>Chronic obstructive pulmonary disease (COPD) is one of the most common serious lung diseases and is unenviably poised to remain the third most common cause of death worldwide well into the mid-century. Patients with COPD struggle with intractable breathlessness that results from airflow limitation, leading to pronounced disability. In practical terms, this means that patients, who characteristically ignore early warnings like reduced exercise capacity, become progressively less able to perform ordinary activities, even dressing and showering, without breathlessness (dyspnea). As the disease progresses, dyspnea may occur at rest and become intractable. Dyspnea leads to a profound loss in productivity and quality of life, alongside suffering, which is often compounded by recurrent chest infections and major comorbidities, especially affecting the heart and circulation, kidneys, metabolism, central nervous system (CNS), and the musculoskeletal system. Lung cancer is also common.</p><p class="" id=d15775e155>COPD is most commonly associated with exposure to inhaled irritants, especially cigarette smoking. However, the pattern of disease is changing markedly and as much as 30 to 40% of prevalent COPD may not relate to current smoking. In the recent CanCOLD (Canadian Cohort of Obstructive Lung Disease) study, a large Canadian population survey, 27% of all COPD was in never-smokers<sup><a href="#ref-1">1</a></sup>. Better educated and more affluent countries have seen dramatic falls in smoking prevalence in men and women. In poorer countries, adverse indoor air quality, massively increasing exposures to environmental inhaled pollutants, and an increasing number of children born with low lung function consequent to economic adversity are now emerging as major drivers of future COPD.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e165>New bronchodilators</h2><p class="" id=d15775e168>In contrast to asthmawhere airflow limitation is caused by excessive airway mucosal inflammation and bronchial smooth muscle contraction, both of which respond well to dual steroids-bronchodilator therapyairflow limitation in COPD is characteristically poorly reversible. The reason for this difference is that COPD results from pronounced damage to the delicate architecture of the lungs that, at least with current technology, cannot be reversed, whereas in asthma the underlying lung architecture remains largely intact. Given that the structural basis of airflow limitation in COPD is currently intractable, pharmaceutical research has made the most progress in refining drug classes already known to be effective in COPD.</p><p class="" id=d15775e171>Both M3 cholinoceptor-favoring long acting anti-muscarinic (LAMA) and long-acting beta-2 adrenoceptor agonist (LABA) bronchodilators work alone or in combination in COPD to improve lung function, reduce gas trapping, and reduce exacerbations. The last several years have seen the introduction of a large number of new agents, and their combinations, for once- or twice-daily use, often and now controversially, co-formulated with an inhaled glucocorticosteroid (ICS)<sup><a href="#ref-2">2</a><a href="#ref-6">6</a></sup>. Broadly, LAMAs produce a slightly larger peak bronchodilator effect than LABAs, perhaps because inflamed COPD tissue produces <i>non-</i>neuronal acetlycholine in abundance<sup><a href="#ref-7">7</a></sup> and the combination of adding a LABA to a LAMA adds about 30 to 40% more effect. New molecules combining both LABA and LAMA properties in a single molecule, so-called MABAs (dual muscarinic antagonist-beta 2 adrenoceptor agonists), are undergoing clinical trial but have not yet been approved. LAMAs have been shown to improve some aspect of tissue remodeling but there is clear evidence that this does not lead to an amelioration of lung function decline. Phosphodiesterase (PDE4) inhibitors, which like LABAs increase cAMP, improve forced expiratory volume in 1 second (FEV1), probably by reducing airways inflammation, but do not convincingly produce clinical bronchodilation.</p><p class="" id=d15775e188>Airway smooth muscle is neither hypertrophic or hyperplastic in COPD, unlike in asthma. Interestingly, taking the lead from severe asthma, a modified form of bronchial thermoplasty called targeted lung denervation (TLD), which uses a water-cooled probe tip to ablate nerve fibers rather than smooth muscle, has proven effective in several small and uncontrolled trials but it is not known whether this approach truly reduces cholinergic drive or interrupts afferent sensory fibers that contribute to the sensation of dyspnea<sup><a href="#ref-8">8</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e198>Chronic obstructive pulmonary disease molecular pathogenesis</h2><p class="" id=d15775e201>It is also important to understand that COPD is an umbrella term that encompasses several distinct pathologies: emphysema, bronchiolitis, and bronchitis. The first of these, emphysema, is where the lung parenchymal tissue comprising the alveolar gas exchange units is progressively destroyed. This leads to reduced net surface area for gas exchange (measured clinically as the diffusing capacity to carbon monoxide, or DLCO), restricting oxygen uptake and carbon dioxide release. Emphysema also directly causes airflow limitation because microscopic elastin fibers in alveolar units operate as molecular springs by tethering the smallest airways open during expiration when compressive forces would otherwise tend to cause them to close. When these fibers are lost, the fragile small airways collapse, trapping gas in the lungs and in turn leading to overinflation, especially during exercise (dynamic hyperinflation)<sup><a href="#ref-9">9</a></sup>. Emphysema is itself heterogeneous and shows marked variation in clinical presentation, which is most likely genetically regulated<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d15775e212>Murine modelsdespite the important caveats that mouse lung repairs emphysema well and has a less airway complex architecture than human lunghave identified multiple molecular candidate processes (see <a href="#f1">Figure 1</a>). These include the following: (i) activation of nuclear factor kappa B (NFB)-dependent and other forms of inflammation. Damage caused by inflammation is compounded by intense oxidant damage which is intensified by impaired protection from NRF2 (nuclear factor [erythroid-derived 2]-like 2, an anti-oxidant master switch)<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup> and depletion of anti-oxidants such as extracellular superoxide dismutase (SOD3)<sup><a href="#ref-13">13</a></sup>. These process may also trigger apoptosis often via the intrinsic stress response activation, which may involve the unfolded protein responses and excessive or unbalanced destruction of proteins by the E3-ligase:26S proteasome system<sup><a href="#ref-14">14</a></sup>; (ii) uncompensated cycles of inflammation and damage that destroy parenchyma in association with elastolysis (first observed in the 1970s<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>), intracellular autophagy and apoptosis driven by reduced endothelial survival factors and DNA damage, notably vascular endothelial growth factor<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>, and excessive ceramide<sup><a href="#ref-19">19</a></sup>. (iii) (dys)regulation of alveolar progenitor pool maintenance and reprogramming of macrophages toward pathogenic rather than pro-resolution phenotypes<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>; (iv) accelerated senescence (aging) associated with activation of p21 and telomere shortening<sup><a href="#ref-22">22</a></sup>; (v) autoimmune and auto innate processes concomitant with the emergence of bronchus-associated lymphoid tissue (BALT) and auto-antibodies that may be linked with aberrant interleukin-23/17 (IL-23/17) over-production, which is possibly linked to inflammasome activation itself<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>; (vi) acquisition of mutations in the stem cell/progenitor pool that alter daughter cell phenotype and function<sup><a href="#ref-25">25</a></sup>; (vii) epigenetic imprinting via acetylation, methylation and emergence of non-coding (dys) regulatory RNAs<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>; (vii) extensive chemical damage to the extracellular matrix (ECM) by oxidation, nitrosylation, carbonylation, and cross-linking that alters its ability to maintain normal cell phenotype via appropriate adhesion kinase signaling<sup><a href="#ref-28">28</a></sup>; and (viii) the worsening of the above by breakdown of mucosal immunity, resulting in recurrent viral infections and bacterial colonization<sup><a href="#ref-29">29</a></sup>. Furthermore, mouse models have delineated important candidate pathways in the development of hypoplastic small lungs with reduced alveolarization that may predispose to early-onset disease. Key pathways implicated in these aberrations are the Wnt-Beta catenin system and the interplay of transforming growth factor-beta (TGF) isoforms with differential signal transduction via signal-transducing intermediates in the TGF system (SMADs)<sup><a href="#ref-27">27</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure1.gif"><img alt="f47e1334-b39a-40c7-a86f-284e84e20160_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure1.gif"></a><div class=caption><h3>Figure 1. Major known mechanisms causing emphysema and small airway disease.</h3><p id=d15775e304>The figure schematizes major pathways identified in experimental models which have reasonable human translational replication. (<b>1</b>) <i>In utero</i> and early life insults that restrict lung growth and retard alveolization. (<b>2</b>) A large group of mechanisms that integrate inflammation and defective immunity with destruction of elastin and collagen fibers required to maintain lung recoil and strength. These include dysregulation of SRC family kinases such as HCK, over-production of interferon gamma (IFN), and dysregulation of collagenases and elastases which are exemplified here as matrix metalloproteinase 12 (MMP12) and MMP1 but which also include neutrophil elastase and other serine proteases and defects in anti-proteases; serpinopathies, notably A1AT deficiency; dysregulation of the transforming growth factor beta (TGF)-mediated homeostasis; and defects in Toll-like receptor (TLR) receptor signaling. (<b>3</b>) Defects in microcirculation leading to excessive apoptosis and alveolar endothelial cell death. For convenience, linked molecular processes, which are not restricted to the endothelium, are shown; these include dysregulation of AKT-mediated cell survival and apoptosis, cell and mitochondrial stress linked to autophagy, and protein damage and misfolding linked to E3-ligase-mediated destruction and accelerated molecular aging associated with defective sirtuin and telomerase activities. (<b>4</b>) Defects in the epithelium (and progenitors including basal cells and stem niche cells) such as impaired CFTR function, ciliostasis, trans-differentiation toward a mucosecretory phenotype, and epithelial-mesenchymal transition (EMT). (<b>5</b>) Autoimmune destruction of tissue. (<b>6</b>) Structurally weakened lung tissue may literally rip when strained following hyperinflation and coughing. The shaded box denotes a wide group of known modifiers and cofactors found in genetic (genome-wide association study and eQT), profiling, and functional studies that predispose or amplify these driving processes: oxidative and mitochondrial stress leading to excessive oxidative damage; defective biotransformation (e.g., by cytochrome p450 isozymes and epoxide hydrolases of inhaled toxins in smoke and pollution that worsen injury); central nervous system genes controlling nicotine addiction, mainly the CHRNA3/5 nicotinic cholinoceptor; weakened catabasis/resolution; hypofunction of the vitamin D axis; EMT especially affecting small airways; iron homeostasis predisposing to infection and excessive oxidative stress; lung growth and repair; immunity and mucosal failure; and molecular aging and senescence. IL, interleukin; VEGF, vascular endothelial growth factor.</p></div></div><p class="" id=d15775e333>The second pathological feature is bronchiolitis, where the smaller airways become inflamed and fibrotic, again limiting airflow. There is important recent evidence from cross-sectional studies that very early in the course of COPD natural history in a dramatic destructive pruning of total small airways may occur well before overt changes in lung function measured by FEV1 occurs<sup><a href="#ref-30">30</a></sup>. Because total resistance to airflow depends on the total cross-sectional area of these small airways, this may contribute to permanent and intractable airflow limitation. Much less attention has been given to this area, mostly because mice do not have airway structures directly analogous to human small bronchioles. Nevertheless, the recent focus on epithelial-mesenchymal transition mechanisms based on advances in cancer research suggests that this process is active in COPD, driven by smoke, and involved in small airway fibrosis (see <a href="#f2">Figure 2</a>)<sup><a href="#ref-31">31</a></sup>. Similarly, the interplay of gp130 and SMADs, signaling intermediates for IL-6 family cytokines and TGF, respectively, is implicated in both airway fibrosis and emphysema<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. Both of these pathways also drive cancer progression and alteration in ECM composition. Although it has not been formally demonstrated for COPD, even subtle changes in ECM can drive forward cancer risk by altering cell phenotypic signaling via focal adhesion kinases and mechanosignaling components such as YAP/TAZ (a Yes-associated protein/transcriptional coactivator with PDZ-binding motif), transcription factors in the Hippo signaling system<sup><a href="#ref-34">34</a></sup>.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure2.gif"><img alt="f47e1334-b39a-40c7-a86f-284e84e20160_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure2.gif"></a><div class=caption><h3>Figure 2. Smoke damages immunity from almost the first exposure.</h3><p id=d15775e369>However, no single mechanism accounts for the deep and widespread impairment of immunity. Instead, the figure shows the interplay of EARLY/RAPID events, a period of DYS-HOMEOSTASIS where key damping feedback mechanisms and defenses are impaired, enabling LATE/SLOW processes that mark intractable inflammation and damage. These are notionally arranged, clockwise, as a temporal progression, but the exact sequence is not known. Ciliostasis and impaired mucociliary clearance (MCC) are prominent immediate effects of smoke, which also induces oxidant stress and inactivates/depletes anti-oxidants, allowing a large number of host defense pathways such as Toll-like receptor (TLR) and other pattern recognition receptors (PRRs) to be impaired. Similarly, a wide range of non-specific innate defense molecules, such as collectins and defensins (collectively called defenders here) become damaged. Macrophages quickly have their phagocytic capacity impaired for bacteria and dead cells (efferocytosis), contributing to impaired catabasis (resolution). Antigen-presenting cells (APCs) become hypofunctional. Chemical stressors epigenetically imprint tissue, and macrophages are redirected to an aberrant M1lo-M2partial maladapted phenotype. Innate cells and lymphocytes (ILCs) function poorly. Errors in iron handling promote further oxidation (e.g., via Fenton reactions) and promote bacterial growth as iron availability is rate-limiting. Colonization occurs in many patients. Extensive chemical modification of extracellular matrix (ECM) alters the tissue microenvironment, and internal post-translational modification (PTM) of cell proteins triggers stress and misfolded protein reactions attenuating key signaling pathways. At this point, comorbid conditions may become apparent. Later, B-cell humoral immunity wains, compounding normative immune aging; immune checkpoint blockers are increased, attenuating viral host defense; T cells become exhausted; and ectopic germinal centers form, promoting autoantibodies. The chemical stress on epithelium leads to somatic mutations, promoting auto-inflammation and, in a smaller group of patients, malignant transformation.</p></div></div><p class="" id=d15775e376>COPD is also often associated with bronchitis, the excessive production of mucus, which may be purulent (infected), especially during exacerbations. This is due to two processes: expansion of mucous glands which are found only in the larger cartilage-containing airways, and trans-differentiation of the smaller airway epithelium away from ciliated and non-secretory epithelial cell phenotypes toward a pattern rich in mucus-secreting goblet (mucus) cells. The molecular regulation of growth of mucous glands, greatly informed by breast cancer research on milk duct development, and the control mechanisms of epithelial progenitor/stem cell lineage regulation and epithelial transdifferentiation are areas of important progress<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Unsurprisingly, IL-13 and epidermal growth factor (EGF)-related signaling pathways are strongly implicated<sup><a href="#ref-37">37</a></sup>, but it is not yet known whether EGF receptor tyrosine kinase (EGF-RTK) or IL-13 (or IL-4Ra) inhibitors are effective. Recent genetic studies also point to genetic control of hypersecretion in COPD<sup><a href="#ref-38">38</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e397>The comorbidome</h2><p class="" id=d15775e400>These classic descriptors of the lung pathology of COPD do not capture the full extent of the health burden because COPD is consistently associated with comorbidities. Given that the structural damage in COPD cannot be reversed with current technology and current treatments are purely symptomatic, there is great need to diagnose and treat chronic concomitant diseases that are modifiable by treatment (cardiovascular diseases, diabetes, osteoporosis, myodebilitation [musculo-skeletal impairment], cancer, and so on). About half of all patients with COPD die from a disorder of the heart and circulation, especially right heart failure, pulmonary hypertension, and thromboembolic disorders such as stroke, myocardial infarct, and deep vein thrombosis (DVT) (the incidence of which increases markedly after exacerbations). Moreover, COPD can be viewed as the lung expression of a multi-morbidome which extends to CNS affective disorder, metabolic derangement, renal disease, cancer (especially lung cancer), and musculoskeletal impairment<sup><a href="#ref-39">39</a></sup>. The role of systemic inflammation as a driver of the comorbidome is suggested by increases in systemic inflammatory biomarkers<sup><a href="#ref-40">40</a></sup>. The first US Food and Drug Administration (FDA)-approved biomarker for COPD interventional trials, fibrinogen, which tracks with increased cardiovascular risk<sup><a href="#ref-41">41</a></sup> and predicts hospitalization and all-cause mortality in COPD, was approved in July 2015 after 6 years of work by the COPD Biomarker Qualification Consortium (CBQC). The broad hope is that future COPD drugs, perhaps systemic anti-inflammatory agents, that reduce fibrinogen correlate with better cardiovascular system (CVS), exacerbation, and mortality outcomes. Recent research demonstrating that defects in endothelial stem cells secondary to DNA damage (via oxidative stress?) and induced senescence, both implicated in emphysema progression, also occur in CVS disease in COPD provides a molecular basis for CVS comorbidity<sup><a href="#ref-17">17</a></sup>. The first major attempt in this direction, the SUMMIT trial (Study to Understand Mortality and Morbidity in COPD), which involved 16,485 patients and tested the hypothesis that combination therapy (fluticasone furoate, a glucocorticosteroid, and vilanterol, a LABA) might reduce all-cause mortality, was recently competed. Although this trial (available only as a press release at the time of this writing) failed to reach statistical significance on its primary and secondary endpoints, the investment in trials of this scale and ambition will shape the terrain and expectations of future COPD interventions<sup><a href="#ref-42">42</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e426>Impediments to clinical translation: the early disease problem</h2><p class="" id=d15775e429>Despite this depth of basic knowledge, clinical translation in COPD has been extremely disappointing to date. At the macro level, there are several major impediments to progress. Firstly, despite excellent basic science, we do not understand COPD clinical endotypes. Endotypes are the underlying molecular pathways that drive clinically observed phenotypes<sup><a href="#ref-43">43</a></sup>. A given clinical phenotype (e.g., emphysema) may result from very distinct endotype pathways; as discussed above, multiple emphysema pathways have been found in preclinical model systems. Whereas we are now moving toward endotyping asthma into molecularly defined subgroups with matched precision medicines<sup><a href="#ref-44">44</a></sup>, COPD languishes in a phase of loose clinical phenotypic clustering, such as the new GOLD 4 quadrant ABCD system, that is pragmatic but imprecise. Secondly, as most COPD is diagnosed very late into its course, the currently approved FDA clinical trial outcomes are difficult to achieve; for example, current regulations require improvement in FEV1, a lung function parameter that is almost entirely insensitive to early changes in small airways. Recent clinical trials have therefore favored exacerbations as a primary outcome because, although loosely defined as worsening of a patients condition requiring a change in usual care, they are quantitative and can be linked to economic costs. In contrast there are no approved outcome measures for clinical trials that might instead try to target early disease. Critically, there is currently no FDA-approved way to study potential benefits of new drugs/therapies in early or pre-COPD<sup><a href="#ref-45">45</a></sup>. Two other CBQC biomarkersthe St Georges Respiratory Questionnaire (SGRQ) and the 6-minute walk test (6MWT)have very recently achieved FDA-approval as trial endpoints. Other tools such as the widely used BODE (a multidimensional grading system that evaluates body mass index, measure of airflow obstruction, dyspnea score, and exercise capacity) index, the COPD Assessment Test (CAT), and EXACTPRO (a COPD exacerbation measurement tool) are not accepted as FDA biomarkers. These tests are invaluable but are weighted to dysfunction in advanced disease and are probably not sensitive to early disease. Lastly, COPD trials are almost the opposite of cancer, the field where precision medicine is most impressive in delivering new treatments. In cancer, drugs made for defined molecular lesions can be tested in pre-selected molecularly stratified patients and validated quickly against relatively easy and rapid trial endpoints, such as tumor size and progression-free survival. Accordingly, cancer trials are booming. COPD lacks endotypes, matched precision drugs, and rapid surrogates.</p><p class="" id=d15775e444>Thus, there is a profound need to develop trial strategies for early disease interventions that use molecular endotype stratification and have relatively quick surrogate outcomes that meet the rigorous standards demanded by regulatory authorities. What then are the most promising areas for translational medicine research in COPD?</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e451>Lung function trajectories</h2><p class="" id=d15775e454>In the late 1970s, Fletcher and Peto described an accelerated decline in lung function in current smokers and its flattened trajectory on cessation, cementing a dominant paradigm of COPD progression<sup><a href="#ref-46">46</a></sup> which has subsequently been expanded<sup><a href="#ref-47">47</a></sup>. In 2015, Lange and colleagues questioned whether the normal decline in lung function that occurs with aging might lead to COPD if initial lung function levels were low<sup><a href="#ref-48">48</a></sup>. By combining three independent cohort studies (Framingham Offspring Cohort, Copenhagen City Heart Study, and Lovelace Smokers Cohort), they demonstrated unequivocally that low initial lung function (&lt;80% FEV1 predicted assessed at age 40) leads to COPD in later life. In the same study, about half of those with normal lung function at age 40 had a rapid decline in lung function (53  23 ml/year) and developed COPD, whereas the rest had slower decline despite similar smoke exposure. This study has several major implications. Firstly, at the public health level, it will be important to develop interventions to maximize lung function very early in life: known impediments to lung growth begin <i>in utero</i> and include infection, maternal smoking, poor maternal nutrition and post-partum exposure to irritants, poor nutrition, and low physical activity. Secondly, rapid decliners represent a prime target for early intervention in COPD prophylaxis studies. The accelerated decline may even start earlier because the study by Lange and colleagues used FEV1 as the lung function measure, which, though well suited to population studies, is quite insensitive to small airway changes. In independent studies, Hogg and colleagues have proposed that the primary lesion in COPD is the loss of small airways, which may precede development of emphysema of a grade sufficiently overt to impair FEV1<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d15775e476>Two other studies point to other strategies for possible early intervention in COPD. Jensen and colleagues reported on disease trajectories in a 6.2 million-patient-strong database, assessing where the temporal relationship between codified health-care utilization could be assessed<sup><a href="#ref-49">49</a></sup>. Their data point to interesting patterns in which a COPD diagnosis is often preceded by a cluster of angina, atherosclerosis, and type II diabetes. More importantly, the post-diagnosis trajectories very frequently involve chest and other infections (cystitis and septicemia). A further important trajectory was muscle weakness, which can cause falls leading to life threatening fracturesespecially when compounded by osteoporosis which is also very common in COPD. Using a similar strategy to question what precedes COPD, Jones and colleagues retrospectively examined a large UK general practice cohort and found a striking increase in both the number of courses of prescribed antibiotics for respiratory tract infections and chest x-rays (presumptive pneumonias), the frequency of which rose exponentially beginning around 18 years prior to COPD diagnosis suggesting that impairment of mucosal immunity occurs early in the natural history of COPD<sup><a href="#ref-50">50</a></sup>.</p><p class="" id=d15775e487>These data suggest two strategies: early life intervention to maximize lung structure and function and disease-modifying interventions in adults, ideally in the very early and presymptomatic phase of disease. Both will be extremely difficult because there are no agreed surrogate endpoints to enable clinical trials of reasonable duration. Furthermore, we lack safe and proven methods to detect early damage to alveoli and small airways. However, recent progress in high-resolution computed tomography (CT) imaging, which can detect benefits in alpha-1 anti-trypsin (A1AT) replacement therapy, provides a way forward, at least in adults.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e493>Impaired mucosal and systemic immunity</h2><p class="" id=d15775e496>These studies also point to the much underestimated impairment of mucosal and systemic immunity that proceeds hand-in-hand with the development of COPD, underlying the increased propensity for viral and bacterial respiratory tract infections, colonization, and possibly cancer and autoimmune disease risk<sup><a href="#ref-29">29</a></sup>. At least 30% of patients with COPD are colonized, and recent metagenome studies suggest the percentage is probably higher<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. Intuitively, colonization of the lung might reasonably be expected to drive chronic inflammation; however, this has been an area of controversy because isolates of <i>Haemophillus influenza</i> obtained from <i>stable</i> disease are not markedly pro-inflammatory in comparison with isolates obtained during a new exacerbation<sup><a href="#ref-53">53</a></sup>. This suggests adaption and even a near-commensal status for long-term colonizing pathogens. In one of the most elegant studies of recent years, Hogg and colleagues questioned whether the altered metagenome in COPD does indeed drive innate immunity and pro-inflammatory pathways. They extracted RNAs from archived lung and concurrently sequenced the metagenome and the host transcriptome, allowing the clear host response pattern to be matched with objective evidence of infection <i>in situ</i><sup><a href="#ref-54">54</a></sup>.</p><p class="" id=d15775e527>There are two major implications for future therapy. Firstly, the simple strategy of trying to suppress the excessive inflammation in COPD with anti-inflammatory drugs or mediator-specific inhibitors of inflammation, an idea borrowed from the highly effective use of ICS, will be fraught with difficulty because, as has already been seen with anti-tumor necrosis factor biologicals<sup><a href="#ref-55">55</a></sup> and the increased pneumonia risk that is a dose-proportional risk with ICS use<sup><a href="#ref-56">56</a><a href="#ref-60">60</a></sup>, the main consequence is increased infection risk rather than clinical improvement. This has already led to great interest in stratifying (restricting) ICS use in COPD to patients with elevated blood eosinophils, the same target group for treatment with eosinophil targeting anti-IL-5 or IL-5R-alpha antibodies that show glimmers of promise<sup><a href="#ref-61">61</a></sup>. Secondly, we must instead develop new drugs to restore mucosal immunity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e548>Catabasis?</h2><p class="" id=d15775e551>Therefore, a much better future strategy, it is argued here, is to find ways to restore defective immunity. One viable strategy is to recapitulate catabasis (resolution) by the use of specialized pro-resolving mediators such as resolvins and lipoxins which dampen inflammation but increase host defense<sup><a href="#ref-62">62</a></sup> and are defective in COPD<sup><a href="#ref-63">63</a></sup>. However, at least for lipoxin A4, the vast amounts of serum amyloid protein A (SAA) released from pathogenic macrophages and other sources may allosterically impair ALX, the lipoxin A4 receptor<sup><a href="#ref-64">64</a></sup>. Another viable strategy is to target the very aberrant development and functional inactivation of lung macrophages. Schultze and colleagues<sup><a href="#ref-65">65</a></sup> recently reported compelling integrative system transcriptomic data demonstrating that host defense functions in COPD macrophages are almost entirely inactivated, providing a molecular architecture to explain functional defects first observed by Hodge and colleagues<sup><a href="#ref-66">66</a></sup>. Given that the molecular regulation of pathogenic macrophage phenotypes is increasingly better understood, it may prove possible to redirect lineage commitment without impairing host defense or worsening inflammation<sup><a href="#ref-20">20</a>,<a href="#ref-67">67</a><a href="#ref-71">71</a></sup>. Lack of type 1 interferons (e.g., interferon beta [IFN]) predisposes COPD patients to viral infection, and inhalation repletion studies show some possibilities in experimental viral challenge models<sup><a href="#ref-72">72</a></sup>, but it is not known whether this pathway also promotes resolution.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e592>Targeting myodebilitation</h2><p class="" id=d15775e595>Exacerbations of COPD leading to hospitalization are arguably the most important drivers of deterioration and overall economic cost and represent a major clinical trial outcome measure. As bed rest, steroid use, and inflammatory burden all compound to weaken already-frail patients, hospital stay itself is a risk factor for costly readmission. However, there are few predictors of which patients are more likely to need readmission which would be useful to structure targeted care, such as strength and conditioning training. Kon and colleagues have recently validated a new assessment tool, the 4-minute gait speed test (4MGS), as a simple predictor<sup><a href="#ref-73">73</a></sup> of frailty and likelihood of readmission<sup><a href="#ref-74">74</a></sup> but this index has not been qualified for regulatory purposes. Similarly, recent advances in high-resolution CT imaging of COPD have confirmed that markedly damaged lung architecture is a readmission risk<sup><a href="#ref-75">75</a></sup>. These articles point to an important area of emerging research, which is the interface of the COPD lung with myodebilitation, also reflected in osteopenia/poris and increased fall risk, which compound risk of life-threatening fractures<sup><a href="#ref-76">76</a></sup>.</p><p class="" id=d15775e614>Several interventions have demonstrated the possibility of at least partially reversing the loss of muscle strength and mass, which occurs more commonly than widely appreciated. One very attractive strategy is to target the activin type II receptor (bimagrumab, BYM338), which represses muscle growth when activated by myostatin, activin, and other growth/differentiation factors that are over-produced in COPD. This strategy has proven effective in increasing human skeletal muscle size and, if combined with physiotherapy, might mitigate myodebilitation<sup><a href="#ref-73">73</a>,<a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup>. Other strategies include activating the ghrelin axis and insulin-like growth factor-1 (IGF-1) repletion, notwithstanding possible side-effect liabilities.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e630>Asthma chronic obstructive pulmonary disease overlap syndrome</h2><p class="" id=d15775e633>Lastly, it is worth considering the fraught category of ACOS. Early epidemiological studies in The Netherlands in the 1960s suggested that traits classically associated with asthma, specifically bronchial hyper-reactivity and atopy, were risk factors for progressive airflow limitation in COPD, sparking an enduring debate on differential diagnosis. Currently, there is intense debate on whether ACOS is a distinct entity, an expression of both asthma and COPD in the same patient given that up to 30% of asthmatics smoke, or an iatrogenic condition given that steroid treatment in severe asthma, which can have partially irreversible airflow limitation, kills eosinophils (the putative asthma mediator) but spares neutrophils (the putative COPD mediator). Patients with ACOS often have more severe disease, more airway involvement, and less emphysema. One intellectually interesting subtheme in the ACOS debate is to move away from the terms asthma and COPD<sup><a href="#ref-35">35</a>,<a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup> and instead concentrate on disease traits, also recently termed treatable traits, a concept well aligned with endotyping strategies<sup><a href="#ref-43">43</a></sup>. A second and pragmatic aspect is that ACOS provides a rationale to treat COPD patients with elevated eosinophils with ICS to minimize pneumonia risk and allocate expensive future biological medicines currently in development such as dupilumab (IL4Ra), mepolizumab (IL-5), and benralizumab (IL5Ra), see <a href="#f3">Figure 3</a>.<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>. It has been suggested that ACOS is part of a disease spectrum<sup><a href="#ref-82">82</a></sup>, and clinical clustering studies using sputum profiling support overlapping ACOS, COPD, and asthma biomarker clusters<sup><a href="#ref-83">83</a></sup>, but the evidence for a molecular spectrum is not strong. Consistent with earlier pediatric epidemiology studies which found that severity level in asthma was set very early in life, longitudinal studies in adults point to ACOS being a fixed airflow consequence of more severe lifelong asthma<sup><a href="#ref-84">84</a></sup>. Asthma is classically not associated with emphysema and loss of elastic recoil, but Nadel and colleagues have recently reported a case series of non-smoking asthmatics with micro-centrilobular emphysema<sup><a href="#ref-85">85</a></sup>. An early genome-wide association study (GWAS) suggested several shared candidate asthma and COPD susceptibility loci, but these were not replicable<sup><a href="#ref-86">86</a></sup>. However, IL-13 has been implicated in both asthma and COPD<sup><a href="#ref-87">87</a></sup>, and direct profiling of genomic signatures in the mucosa of patients with COPD has unequivocally identified a T2 (TH2) gene signature in a subset of patients (that was not revealed by classic history-taking) showing elevated T2 biomarkers<sup><a href="#ref-88">88</a></sup>. An important caveat of these studies is that gene expression is quite fluid in COPD, especially in ICS-treated patients<sup><a href="#ref-89">89</a></sup>. Similarly, chitinases, which are classically induced by T2 signals, are elevated in more severe COPD. More recent GWAS of ACOS have identified single-nucleotide polymorphisms in candidate genes<sup><a href="#ref-90">90</a></sup>. It is also not known whether the T2-high gene signature observed in ACOS is mediated by classic TH2 CD4<sup>+</sup> lymphocytes or, more likely, ILC2 innate lymphoid cells, an important matter because of their differential (re)activation and pharmacological profiles. Tissue damage, whether by smoke or viruses, releases substantial amounts of IL-33, an alarmin able to concurrently reactivate both ILC2 cells linked to T2 cytokines, and a separate macrophage and natural killer cell effector arm linked to IFN and IL-12, Th1-cytokines, as elegantly demonstrated by Humbles and colleagues<sup><a href="#ref-91">91</a></sup>. In the same study, however, active smoke exposure paralyzed ILC2 cells, favoring an exaggerated T1 response<sup><a href="#ref-91">91</a></sup>. Collectively, therefore, ACOS appears to have a molecular basis that, on present evidence, is best considered a co-expression of T2 immunity in the context of COPD.</p><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure3.gif"><img alt="f47e1334-b39a-40c7-a86f-284e84e20160_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/7556/f47e1334-b39a-40c7-a86f-284e84e20160_figure3.gif"></a><div class=caption><h3>Figure 3. Asthma COPD overlap syndrome (ACOS) is a very poorly defined set of clinical presentations having some features of both asthma and COPD.</h3><p id=d15775e719>There is good evidence that eosinophils are a clinically relevant trait as inhaled steroids are effective in patients with eosinophil-high ACOS, and anti-eosinophil monoclonal antibodies (e.g., mepolizumab, anti-IL-5, benralizumab, and anti-IL-5 receptor) have shown some promise to reduce exacerbations in COPD/ACOS in early clinical trials. ACOS has a clear T2-biased gene signature on profiling studies, but it is not yet known whether T2 blockers such as dupilumab (anti-IL-4 receptor alpha), which show promising efficacy in phase III clinical trials in asthma, will also be of benefit in ACOS. Interesting macrolides, which probably target the altered metagenome in both conditions, may also be effective in some patients with ACOS. Bronchodilators such as long-acting beta-2 adrenoceptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) provide symptomatic relief but do not alter disease processes. Names in bold denote level A or B clinical trial evidence. Names in italics refer to early phase II clinical trial evidence or speculation based on mode of action. COPD, chronic obstructive pulmonary disease; IL, interleukin.</p></div></div><p class="" id=d15775e726>This short review is by no means a comprehensive survey of COPD and its science over the last several years. It has instead lionized certain emerging themes that stress the need to transition COPD research away from clinical phenotyping toward molecular endotyping and, most critically, to develop the clinical research tools and systems needed to intervene much earlier in disease, when lung function is preserved and pathogenic processes are most likely to be tractable to therapy. In late disease, the importance of frailty and myodebilitation, as well as impaired immunity, have been emphasized as tractable and highly attractive fields of future research.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15775e732>Abbreviations</h2><p class="" id=d15775e735>ACOS, asthma chronic obstructive pulmonary disease overlap syndrome; CBQC, COPD Biomarker Qualification Consortium; COPD, chronic obstructive pulmonary disease; CNS, central nervous system; CT, computed tomography; CVS, cardiovascular system; ECM, extracellular matrix; EGF, epidermal growth factor; FDA, US Food and Drug Administration; FEV1, forced expiratory volume in 1 second; GWAS, genome-wide association study; ICS, inhaled glucocorticosteroid; IFN, interferon; IL, interleukin; ILC2, type 2 innate lymphocyte; LABA, long-acting beta-2 adrenoceptor agonist; LAMA, long-acting muscarinic antagonist; SMAD, signal-transducing intermediates in the transforming growth factor beta system; TGF, transforming growth factor beta.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15775e1 class=n-a></a><h2 class=main-title id=d16061>Competing interests</h2><p class=metadata-entry><a name=d15775e84 class=n-a></a><p id=d15775e86> The author has received advisory board and speaker honoraria from AstraZeneca/MedImmune (Gaithersburg, MD, USA), Boehringer Ingelheim (Ingelheim, Germany), GlaxoSmithKline (Brentford, UK), Janssen (Beerse, Belgium), Mundipharma (Cambridge, UK), and Novartis (Basel, Switzerland). This year, he is undertaking a sabbatical secondment as chief scientist in the AstraZeneca RIA iMED drug discovery division in Cambridge, UK, funded by AstraZeneca.</p></p></div><div class=back-section><a name=d15775e1 class=n-a></a><h2 class=main-title id=d16063>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d15775e742 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d16371>References</h2><div class="section ref-list"><a name=d15775e742 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d15775e749 class=n-a></a>Tan WC, Sin DD, Bourbeau J, <i> et al.</i>: Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. <i>Thorax.</i> 2015; <b>70</b>(9): 8229. <a target=xrefwindow id=d15775e760 href="http://www.ncbi.nlm.nih.gov/pubmed/26048404">PubMed Abstract </a> | <a target=xrefwindow id=d15775e763 href="http://dx.doi.org/10.1136/thoraxjnl-2015-206938">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15775e772 class=n-a></a>Pascoe S, Locantore N, Dransfield MT, <i> et al.</i>: Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. <i>Lancet Respir Med.</i> 2015; <b>3</b>(6): 43542. <a target=xrefwindow id=d15775e783 href="http://www.ncbi.nlm.nih.gov/pubmed/25878028">PubMed Abstract </a> | <a target=xrefwindow id=d15775e786 href="http://dx.doi.org/10.1016/S2213-2600(15)00106-X">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d15775e795 class=n-a></a>Nesterko AO, Sapronenkov PM, Arsen'ev FV, <i> et al.</i>: Dlitel'noe prebyvanie inorodnykh tel v trakheobronkhial'nom dereve. <i>Klin Med (Mosk).</i> 1989; <b>67</b>: 1127.</span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15775e813 class=n-a></a>Rossi A, Zanardi E, Poletti V, <i> et al.</i>: Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life. <i>Int J Chron Obstruct Pulmon Dis.</i> 2015; <b>10</b>: 138392. <a target=xrefwindow id=d15775e824 href="http://www.ncbi.nlm.nih.gov/pubmed/26229457">PubMed Abstract </a> | <a target=xrefwindow id=d15775e827 href="http://dx.doi.org/10.2147/COPD.S55488">Publisher Full Text </a> | <a target=xrefwindow id=d15775e831 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4516211">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d15775e840 class=n-a></a>Bateman ED, Chapman KR, Singh D, <i> et al.</i>: Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). <i>Respir Res.</i> 2015; <b>16</b>: 92. <a target=xrefwindow id=d15775e851 href="http://www.ncbi.nlm.nih.gov/pubmed/26233481">PubMed Abstract </a> | <a target=xrefwindow id=d15775e854 href="http://dx.doi.org/10.1186/s12931-015-0250-2">Publisher Full Text </a> | <a target=xrefwindow id=d15775e858 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4531806">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d15775e868 class=n-a></a>Beeh K, Westerman J, Kirsten A, <i> et al.</i>: The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. <i>Pulm Pharmacol Ther.</i> 2015; <b>32</b>: 539. <a target=xrefwindow id=d15775e879 href="http://www.ncbi.nlm.nih.gov/pubmed/25956072">PubMed Abstract </a> | <a target=xrefwindow id=d15775e882 href="http://dx.doi.org/10.1016/j.pupt.2015.04.002">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15775e891 class=n-a></a>Wessler I, Kirkpatrick CJ, Rack K: Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. <i>Pharmacol Ther.</i> 1998; <b>77</b>(1): 5979. <a target=xrefwindow id=d15775e899 href="http://www.ncbi.nlm.nih.gov/pubmed/9500159">PubMed Abstract </a> | <a target=xrefwindow id=d15775e902 href="http://dx.doi.org/10.1016/S0163-7258(97)00085-5">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d15775e911 class=n-a></a>Kistemaker LE, Slebos DJ, Meurs H, <i> et al.</i>: Anti-inflammatory effects of targeted lung denervation in patients with COPD. <i>Eur Respir J.</i> 2015; <b>46</b>(5): 148992. <a target=xrefwindow id=d15775e922 href="http://www.ncbi.nlm.nih.gov/pubmed/26341988">PubMed Abstract </a> | <a target=xrefwindow id=d15775e925 href="http://dx.doi.org/10.1183/13993003.00413-2015">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d15775e934 class=n-a></a>Langer D, Ciavaglia CE, Neder JA, <i> et al.</i>: Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. <i>Expert Rev Respir Med.</i> 2014; <b>8</b>(6): 73149. <a target=xrefwindow id=d15775e945 href="http://www.ncbi.nlm.nih.gov/pubmed/25159007">PubMed Abstract </a> | <a target=xrefwindow id=d15775e948 href="http://dx.doi.org/10.1586/17476348.2014.949676">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15775e957 class=n-a></a>Cho MH, Castaldi PJ, Hersh CP, <i> et al.</i>: A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. <i>Am J Respir Crit Care Med.</i> 2015; <b>192</b>(5): 55969. <a target=xrefwindow id=d15775e968 href="http://www.ncbi.nlm.nih.gov/pubmed/26030696">PubMed Abstract </a> | <a target=xrefwindow id=d15775e971 href="http://dx.doi.org/10.1164/rccm.201501-0148OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e975 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4595690">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d15775e984 class=n-a></a>Cabanski M, Fields B, Boue S, <i> et al.</i>: Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains. <i>Inflamm Res.</i> 2015; <b>64</b>(7): 47186. <a target=xrefwindow id=d15775e995 href="http://www.ncbi.nlm.nih.gov/pubmed/25962837">PubMed Abstract </a> | <a target=xrefwindow id=d15775e998 href="http://dx.doi.org/10.1007/s00011-015-0820-2">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1002 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4464601">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15775e1012 class=n-a></a>Rangasamy T, Cho CY, Thimmulappa RK, <i> et al.</i>: Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. <i>J Clin Invest.</i> 2004; <b>114</b>(9): 124859. <a target=xrefwindow id=d15775e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/15520857">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1026 href="http://dx.doi.org/10.1172/JCI21146">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/524225">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/6370957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e1039 class=n-a></a>Yao H, Arunachalam G, Hwang JW, <i> et al.</i>: Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. <i>Proc Natl Acad Sci USA.</i> 2010; <b>107</b>(35): 155716. <a target=xrefwindow id=d15775e1050 href="http://www.ncbi.nlm.nih.gov/pubmed/20713693">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1053 href="http://dx.doi.org/10.1073/pnas.1007625107">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2932580">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/6370957">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d15775e1070 class=n-a></a>Blumental-Perry A: Unfolded protein response in chronic obstructive pulmonary disease: smoking, aging and disease: a SAD trifecta. <i>Curr Mol Med.</i> 2012; <b>12</b>(7): 88398. <a target=xrefwindow id=d15775e1078 href="http://www.ncbi.nlm.nih.gov/pubmed/22697343">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1081 href="http://dx.doi.org/10.2174/156652412801318764">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d15775e1090 class=n-a></a>Snider GL, Hayes JA, Franzblau C, <i> et al.</i>: Relationship between elastolytic activity and experimental emphysema-induced properties of papain preparations. <i>Am Rev Respir Dis.</i> 1974; <b>110</b>(3): 25462. <a target=xrefwindow id=d15775e1101 href="http://www.ncbi.nlm.nih.gov/pubmed/4415535">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1104 href="http://dx.doi.org/10.1164/arrd.1974.110.3.254">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d15775e1113 class=n-a></a>Tran I, Ji C, Ni I, <i> et al.</i>: Role of Cigarette Smoke-Induced Aggresome Formation in Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis. <i>Am J Respir Cell Mol Biol.</i> 2015; <b>53</b>(2): 15973. <a target=xrefwindow id=d15775e1124 href="http://www.ncbi.nlm.nih.gov/pubmed/25490051">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1127 href="http://dx.doi.org/10.1165/rcmb.2014-0107OC">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d15775e1136 class=n-a></a>Paschalaki KE, Starke RD, Hu Y, <i> et al.</i>: Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. <i>Stem Cells.</i> 2013; <b>31</b>(12): 281326. <a target=xrefwindow id=d15775e1147 href="http://www.ncbi.nlm.nih.gov/pubmed/23897750">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1150 href="http://dx.doi.org/10.1002/stem.1488">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1154 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4377082">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d15775e1164 class=n-a></a>Kasahara Y, Tuder RM, Taraseviciene-Stewart L, <i> et al.</i>: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. <i>J Clin Invest.</i> 2000; <b>106</b>(11): 13119. <a target=xrefwindow id=d15775e1175 href="http://www.ncbi.nlm.nih.gov/pubmed/11104784">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1178 href="http://dx.doi.org/10.1172/JCI10259">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/387249">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d15775e1191 class=n-a></a>Baudi K, Ayata CK, Lazar Z, <i> et al.</i>: Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation. <i>Eur Respir J.</i> 2015; <b>45</b>(6): 166980. <a target=xrefwindow id=d15775e1202 href="http://www.ncbi.nlm.nih.gov/pubmed/25614161">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1205 href="http://dx.doi.org/10.1183/09031936.00080014">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d15775e1214 class=n-a></a>Duan M, Li WC, Vlahos R, <i> et al.</i>: Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. <i>J Immunol.</i> 2012; <b>189</b>(2): 94655. <a target=xrefwindow id=d15775e1225 href="http://www.ncbi.nlm.nih.gov/pubmed/22689883">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1228 href="http://dx.doi.org/10.4049/jimmunol.1200660">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d15775e1237 class=n-a></a>Anthony D, McQualter JL, Bishara M, <i> et al.</i>: SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling. <i>FASEB J.</i> 2014; <b>28</b>(9): 386777. <a target=xrefwindow id=d15775e1248 href="http://www.ncbi.nlm.nih.gov/pubmed/24846388">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1251 href="http://dx.doi.org/10.1096/fj.14-250332">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d15775e1260 class=n-a></a>Rutten EP, Gopal P, Wouters EF, <i> et al.</i>: Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD. <i>Chest.</i> 2016; <b>149</b>(1): 5361. <a target=xrefwindow id=d15775e1271 href="http://www.ncbi.nlm.nih.gov/pubmed/26066545">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1274 href="http://dx.doi.org/10.1378/chest.15-0645">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d15775e1283 class=n-a></a>Seys LJ, Verhamme FM, Schinwald A, <i> et al.</i>: Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease. <i>Am J Respir Crit Care Med.</i> 2015; <b>192</b>(6): 70618. <a target=xrefwindow id=d15775e1294 href="http://www.ncbi.nlm.nih.gov/pubmed/26266827">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1297 href="http://dx.doi.org/10.1164/rccm.201501-0103OC">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d15775e1307 class=n-a></a>Bozinovski S, Seow HJ, Chan SP, <i> et al.</i>: Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice. <i>Clin Sci.</i> 2015; <b>129</b>(9): 78596. <a target=xrefwindow id=d15775e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/26201093">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1321 href="http://dx.doi.org/10.1042/CS20140703">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4613531">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d15775e1334 class=n-a></a>Anderson GP, Bozinovski S: Acquired somatic mutations in the molecular pathogenesis of COPD. <i>Trends Pharmacol Sci.</i> 2003; <b>24</b>(2): 716. <a target=xrefwindow id=d15775e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/12559770">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1345 href="http://dx.doi.org/10.1016/S0165-6147(02)00052-4">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d15775e1354 class=n-a></a>Cheng L, Liu J, Li B, <i> et al.</i>: Cigarette Smoke-Induced Hypermethylation of the GCLC Gene Is Associated With COPD. <i>Chest.</i> 2015. <b>149</b>(2): 47482. <a target=xrefwindow id=d15775e1365 href="http://www.ncbi.nlm.nih.gov/pubmed/26087411">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1368 href="http://dx.doi.org/10.1378/chest.14-2309">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d15775e1377 class=n-a></a>Warburton D, Shi W, Xu B: TGF--Smad3 signaling in emphysema and pulmonary fibrosis: an epigenetic aberration of normal development? <i>Am J Physiol Lung Cell Mol Physiol.</i> 2013; <b>304</b>(2): L835. <a target=xrefwindow id=d15775e1385 href="http://www.ncbi.nlm.nih.gov/pubmed/23161884">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1388 href="http://dx.doi.org/10.1152/ajplung.00258.2012">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4073936">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13420962"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e1400 class=n-a></a>Kirkham PA, Caramori G, Casolari P, <i> et al.</i>: Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2011; <b>184</b>(7): 796802. <a target=xrefwindow id=d15775e1411 href="http://www.ncbi.nlm.nih.gov/pubmed/21965015">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1414 href="http://dx.doi.org/10.1164/rccm.201010-1605OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3398415">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13420962">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d15775e1431 class=n-a></a>Stmpfli MR, Anderson GP: How cigarette smoke skews immune responses to promote infection, lung disease and cancer. <i>Nat Rev Immunol.</i> 2009; <b>9</b>(5): 37784. <a target=xrefwindow id=d15775e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/19330016">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1442 href="http://dx.doi.org/10.1038/nri2530">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d15775e1452 class=n-a></a>Hogg JC, McDonough JE, Suzuki M: Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. <i>Chest.</i> 2013; <b>143</b>(5): 143643. <a target=xrefwindow id=d15775e1460 href="http://www.ncbi.nlm.nih.gov/pubmed/23648907">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1463 href="http://dx.doi.org/10.1378/chest.12-1766">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1466 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3653349">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d15775e1475 class=n-a></a>Sohal SS, Soltani A, Reid D, <i> et al.</i>: A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study. <i>Int J Chron Obstruct Pulmon Dis.</i> 2014; <b>9</b>: 53342. <a target=xrefwindow id=d15775e1486 href="http://www.ncbi.nlm.nih.gov/pubmed/24920891">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1489 href="http://dx.doi.org/10.2147/COPD.S63911">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1493 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4043431">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d15775e1502 class=n-a></a>Knight DA, Ernst M, Anderson GP, <i> et al.</i>: The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? <i>Pharmacol Ther.</i> 2003; <b>99</b>(3): 32738. <a target=xrefwindow id=d15775e1513 href="http://www.ncbi.nlm.nih.gov/pubmed/12951164">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1516 href="http://dx.doi.org/10.1016/S0163-7258(03)00095-0">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15775e1525 class=n-a></a>Ruwanpura SM, McLeod L, Miller A, <i> et al.</i>: Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2012; <b>302</b>(7): L62739. <a target=xrefwindow id=d15775e1536 href="http://www.ncbi.nlm.nih.gov/pubmed/22268122">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1539 href="http://dx.doi.org/10.1152/ajplung.00285.2011">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d15775e1548 class=n-a></a>Seo BR, Bhardwaj P, Choi S, <i> et al.</i>: Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. <i>Sci Transl Med.</i> 2015; <b>7</b>(301): 301ra130. <a target=xrefwindow id=d15775e1559 href="http://www.ncbi.nlm.nih.gov/pubmed/26290412">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1562 href="http://dx.doi.org/10.1126/scitranslmed.3010467">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4837896">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d15775e1575 class=n-a></a>Lynch TJ, Engelhardt JF: Progenitor cells in proximal airway epithelial development and regeneration. <i>J Cell Biochem.</i> 2014; <b>115</b>(10): 163745. <a target=xrefwindow id=d15775e1583 href="http://www.ncbi.nlm.nih.gov/pubmed/24818588">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1586 href="http://dx.doi.org/10.1002/jcb.24834">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1589 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4428157">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d15775e1599 class=n-a></a>McQualter JL, Yuen K, Williams B, <i> et al.</i>: Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(4): 14149. <a target=xrefwindow id=d15775e1610 href="http://www.ncbi.nlm.nih.gov/pubmed/20080639">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1613 href="http://dx.doi.org/10.1073/pnas.0909207107">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2824384">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d15775e1626 class=n-a></a>Lai H, Rogers DF: New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. <i>J Aerosol Med Pulm Drug Deliv.</i> 2010; <b>23</b>(4): 21931. <a target=xrefwindow id=d15775e1634 href="http://www.ncbi.nlm.nih.gov/pubmed/20695774">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1637 href="http://dx.doi.org/10.1089/jamp.2009.0802">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d15775e1646 class=n-a></a>Dijkstra AE, Boezen HM, van den Berge M, <i> et al.</i>: Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. <i>Eur Respir J.</i> 2015; <b>45</b>(1): 6075. <a target=xrefwindow id=d15775e1657 href="http://www.ncbi.nlm.nih.gov/pubmed/25234806">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1660 href="http://dx.doi.org/10.1183/09031936.00093314">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1664 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4498483">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d15775e1673 class=n-a></a>Fabbri LM, Boyd C, Boschetto P, <i> et al.</i>: How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. <i>Proc Am Thorac Soc.</i> 2012; <b>9</b>(5): 27481. <a target=xrefwindow id=d15775e1684 href="http://www.ncbi.nlm.nih.gov/pubmed/23256171">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1687 href="http://dx.doi.org/10.1513/pats.201208-063ST">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d15775e1696 class=n-a></a>Agust A, Edwards LD, Rennard SI, <i> et al.</i>: Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. <i>PLoS One.</i> 2012; <b>7</b>(5): e37483. <a target=xrefwindow id=d15775e1707 href="http://www.ncbi.nlm.nih.gov/pubmed/22624038">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1710 href="http://dx.doi.org/10.1371/journal.pone.0037483">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1714 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3356313">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d15775e1723 class=n-a></a>Kannel WB, D'Agostino RB, Belanger AJ: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. <i>Am Heart J.</i> 1987; <b>113</b>(4): 100610. <a target=xrefwindow id=d15775e1731 href="http://www.ncbi.nlm.nih.gov/pubmed/3565227">PubMed Abstract </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d15775e1741 class=n-a></a>Pharmaceuticals G: GSK and Theravance Announce Results From the SUMMIT COPD CV Survival Study. 2015. <a target=xrefwindow id=d15775e1743 href="http://files.shareholder.com/downloads/THERA/0x0x849452/73D56CE4-1FB0-4D67-9E3B-FDD559314885/THRX_News_2015_9_8_General.pdf">Reference Source</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d15775e1752 class=n-a></a>Anderson GP: Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. <i>Lancet.</i> 2008; <b>372</b>(9643): 110719. <a target=xrefwindow id=d15775e1760 href="http://www.ncbi.nlm.nih.gov/pubmed/18805339">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1763 href="http://dx.doi.org/10.1016/S0140-6736(08)61452-X">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://F1000.com/prime/718011925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e1772 class=n-a></a>Wenzel S, Ford L, Pearlman D, <i> et al.</i>: Dupilumab in persistent asthma with elevated eosinophil levels. <i>N Engl J Med.</i> 2013; <b>368</b>(26): 245566. <a target=xrefwindow id=d15775e1783 href="http://www.ncbi.nlm.nih.gov/pubmed/23688323">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1786 href="http://dx.doi.org/10.1056/NEJMoa1304048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://F1000.com/prime/718011925">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d15775e1799 class=n-a></a>Holgate S, Agusti A, Strieter RM, <i> et al.</i>: Drug development for airway diseases: looking forward. <i>Nat Rev Drug Discov.</i> 2015; <b>14</b>(6): 3678. <a target=xrefwindow id=d15775e1810 href="http://www.ncbi.nlm.nih.gov/pubmed/26000726">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1813 href="http://dx.doi.org/10.1038/nrd4645">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d15775e1822 class=n-a></a>Fletcher C, Peto R: The natural history of chronic airflow obstruction. <i>Br Med J.</i> 1977; <b>1</b>(6077): 16458. <a target=xrefwindow id=d15775e1830 href="http://www.ncbi.nlm.nih.gov/pubmed/871704">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1833 href="http://dx.doi.org/10.1136/bmj.1.6077.1645">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1836 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1607732">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15775e1845 class=n-a></a>Rennard SI, Vestbo J: Natural histories of chronic obstructive pulmonary disease. <i>Proc Am Thorac Soc.</i> 2008; <b>5</b>(9): 87883. <a target=xrefwindow id=d15775e1853 href="http://www.ncbi.nlm.nih.gov/pubmed/19056710">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1856 href="http://dx.doi.org/10.1513/pats.200804-035QC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1859 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2720106">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d15775e1869 class=n-a></a>Lange P, Celli B, Agust A, <i> et al.</i>: Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. <i>N Engl J Med.</i> 2015; <b>373</b>(2): 11122. <a target=xrefwindow id=d15775e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/26154786">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1883 href="http://dx.doi.org/10.1056/NEJMoa1411532">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d15775e1892 class=n-a></a>Jensen AB, Moseley PL, Oprea TI, <i> et al.</i>: Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. <i>Nat Commun.</i> 2014; <b>5</b>: 4022. <a target=xrefwindow id=d15775e1903 href="http://www.ncbi.nlm.nih.gov/pubmed/24959948">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1906 href="http://dx.doi.org/10.1038/ncomms5022">Publisher Full Text </a> | <a target=xrefwindow id=d15775e1910 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4090719">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d15775e1919 class=n-a></a>Jones RC, Price D, Ryan D, <i> et al.</i>: Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. <i>Lancet Respir Med.</i> 2014; <b>2</b>(4): 26776. <a target=xrefwindow id=d15775e1930 href="http://www.ncbi.nlm.nih.gov/pubmed/24717623">PubMed Abstract </a> | <a target=xrefwindow id=d15775e1933 href="http://dx.doi.org/10.1016/S2213-2600(14)70008-6">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15775e1942 class=n-a></a>Losada PM, Tmmler B, Wiehlmann L, <i> et al.</i>: Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis-and COPD patients. <i>Eur Respir J.</i> 2014; <b>44</b>: P1212. <a target=xrefwindow id=d15775e1953 href="http://erj.ersjournals.com/content/44/Suppl_58/P1212">Reference Source</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d15775e1962 class=n-a></a>Garcia-Nuez M, Perez-Brocal V, Pomares X, <i> et al.</i>: Bacterial and viral microbiomes in COPD exacerbations of unidentified cause. <i>Eur Respir J.</i> 2014; <b>44</b>: P2534. <a target=xrefwindow id=d15775e1973 href="http://erj.ersjournals.com/content/44/Suppl_58/P2534.short">Reference Source</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d15775e1982 class=n-a></a>Chin CL, Manzel LJ, Lehman EE, <i> et al.</i>: <i>Haemophilus influenzae</i> from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. <i>Am J Respir Crit Care Med.</i> 2005; <b>172</b>(1): 8591. <a target=xrefwindow id=d15775e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/15805181">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2000 href="http://dx.doi.org/10.1164/rccm.200412-1687OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2718449">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d15775e2013 class=n-a></a>Sze MA, Dimitriu PA, Suzuki M, <i> et al.</i>: Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease. <i>Am J Respir Crit Care Med.</i> 2015; <b>192</b>(4): 43845. <a target=xrefwindow id=d15775e2024 href="http://www.ncbi.nlm.nih.gov/pubmed/25945594">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2027 href="http://dx.doi.org/10.1164/rccm.201502-0223OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2031 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4595667">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/6692956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2040 class=n-a></a>Rennard SI, Fogarty C, Kelsen S, <i> et al.</i>: The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2007; <b>175</b>(9): 92634. <a target=xrefwindow id=d15775e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/17290043">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2054 href="http://dx.doi.org/10.1164/rccm.200607-995OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/6692956">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15775e2067 class=n-a></a>Singh S, Amin AV, Loke YK: Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. <i>Arch Intern Med.</i> 2009; <b>169</b>(3): 21929. <a target=xrefwindow id=d15775e2075 href="http://www.ncbi.nlm.nih.gov/pubmed/19204211">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2078 href="http://dx.doi.org/10.1001/archinternmed.2008.550">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d15775e2087 class=n-a></a>Suissa S, Patenaude V, Lapi F, <i> et al.</i>: Inhaled corticosteroids in COPD and the risk of serious pneumonia. <i>Thorax.</i> 2013; <b>68</b>(11): 102936. <a target=xrefwindow id=d15775e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/24130228">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2101 href="http://dx.doi.org/10.1136/thoraxjnl-2012-202872">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2105 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3812880">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d15775e2114 class=n-a></a>DiSantostefano RL, Li H, Hinds D, <i> et al.</i>: Risk of pneumonia with inhaled corticosteroid/long-acting 2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis. <i>Int J Chron Obstruct Pulmon Dis.</i> 2014; <b>9</b>(1): 45768. <a target=xrefwindow id=d15775e2125 href="http://www.ncbi.nlm.nih.gov/pubmed/24855350">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2128 href="http://dx.doi.org/10.2147/COPD.S60498">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2132 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4019612">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d15775e2141 class=n-a></a>Finney L, Berry M, Singanayagam A, <i> et al.</i>: Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease. <i>Lancet Respir Med.</i> 2014; <b>2</b>(11): 91932. <a target=xrefwindow id=d15775e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/25240963">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2155 href="http://dx.doi.org/10.1016/S2213-2600(14)70169-9">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d15775e2165 class=n-a></a>Kew KM, Seniukovich A: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. <i>Cochrane Database Syst Rev.</i> 2014; (3): CD010115. <a target=xrefwindow id=d15775e2170 href="http://www.ncbi.nlm.nih.gov/pubmed/24615270">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2173 href="http://dx.doi.org/10.1002/14651858.CD010115.pub2">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15775e2182 class=n-a></a>Brightling CE, Bleecker ER, Panettieri RA Jr, <i> et al.</i>: Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. <i>Lancet Respir Med.</i> 2014; <b>2</b>(11): 891901. <a target=xrefwindow id=d15775e2193 href="http://www.ncbi.nlm.nih.gov/pubmed/25208464">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2196 href="http://dx.doi.org/10.1016/S2213-2600(14)70187-0">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725662411"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2205 class=n-a></a>Chiang N, Dalli J, Colas RA, <i> et al.</i>: Identification of resolvin D2 receptor mediating resolution of infections and organ protection. <i>J Exp Med.</i> 2015; <b>212</b>(8): 120317. <a target=xrefwindow id=d15775e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/26195725">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2219 href="http://dx.doi.org/10.1084/jem.20150225">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2223 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4516788">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725662411">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d15775e2236 class=n-a></a>Bozinovski S, Anthony D, Anderson GP, <i> et al.</i>: Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways. <i>Pharmacol Ther.</i> 2013; <b>140</b>(3): 2809. <a target=xrefwindow id=d15775e2247 href="http://www.ncbi.nlm.nih.gov/pubmed/23880288">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2250 href="http://dx.doi.org/10.1016/j.pharmthera.2013.07.007">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d15775e2259 class=n-a></a>Bozinovski S, Uddin M, Vlahos R, <i> et al.</i>: Serum amyloid A opposes lipoxin A<sub>4</sub> to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. <i>Proc Natl Acad Sci USA.</i> 2012; <b>109</b>(3): 93540. <a target=xrefwindow id=d15775e2273 href="http://www.ncbi.nlm.nih.gov/pubmed/22215599">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2277 href="http://dx.doi.org/10.1073/pnas.1109382109">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2280 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3271884">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718278229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2289 class=n-a></a>Xue J, Schmidt SV, Sander J, <i> et al.</i>: Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. <i>Immunity.</i> 2014; <b>40</b>(2): 27488. <a target=xrefwindow id=d15775e2300 href="http://www.ncbi.nlm.nih.gov/pubmed/24530056">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2303 href="http://dx.doi.org/10.1016/j.immuni.2014.01.006">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2307 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3991396">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718278229">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d15775e2321 class=n-a></a>Hodge S, Hodge G, Ahern J, <i> et al.</i>: Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. <i>Am J Respir Cell Mol Biol.</i> 2007; <b>37</b>(6): 74855. <a target=xrefwindow id=d15775e2332 href="http://www.ncbi.nlm.nih.gov/pubmed/17630319">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2335 href="http://dx.doi.org/10.1165/rcmb.2007-0025OC">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d15775e2344 class=n-a></a>Bozinovski S, Jones JE, Vlahos R, <i> et al.</i>: Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 <i>in vivo</i>. <i>J Biol Chem.</i> 2002; <b>277</b>(45): 4280814. <a target=xrefwindow id=d15775e2358 href="http://www.ncbi.nlm.nih.gov/pubmed/12208854">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2362 href="http://dx.doi.org/10.1074/jbc.M207840200">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718270404"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2371 class=n-a></a>Lawrence T, Natoli G: Transcriptional regulation of macrophage polarization: enabling diversity with identity. <i>Nat Rev Immunol.</i> 2011; <b>11</b>(11): 75061. <a target=xrefwindow id=d15775e2379 href="http://www.ncbi.nlm.nih.gov/pubmed/22025054">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2382 href="http://dx.doi.org/10.1038/nri3088">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718270404">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717960742"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2395 class=n-a></a>Gautier EL, Shay T, Miller J, <i> et al.</i>: Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. <i>Nat Immunol.</i> 2012; <b>13</b>(11): 111828. <a target=xrefwindow id=d15775e2406 href="http://www.ncbi.nlm.nih.gov/pubmed/23023392">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2409 href="http://dx.doi.org/10.1038/ni.2419">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2413 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3558276">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717960742">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d15775e2426 class=n-a></a>Lenzo JC, Turner AL, Cook AD, <i> et al.</i>: Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. <i>Immunol Cell Biol.</i> 2012; <b>90</b>(4): 42940. <a target=xrefwindow id=d15775e2437 href="http://www.ncbi.nlm.nih.gov/pubmed/21727904">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2440 href="http://dx.doi.org/10.1038/icb.2011.58">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d15775e2449 class=n-a></a>Anthony D, McQualter JL, Bishara M, <i> et al.</i>: SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling. <i>FASEB J.</i> 2014; <b>28</b>(9): 386777. <a target=xrefwindow id=d15775e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/24846388">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2463 href="http://dx.doi.org/10.1096/fj.14-250332">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d15775e2473 class=n-a></a>Gunawardana N, Finney L, Johnston SL, <i> et al.</i>: Experimental rhinovirus infection in COPD: implications for antiviral therapies. <i>Antiviral Res.</i> 2014; <b>102</b>: 95105. <a target=xrefwindow id=d15775e2484 href="http://www.ncbi.nlm.nih.gov/pubmed/24370732">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2487 href="http://dx.doi.org/10.1016/j.antiviral.2013.12.006">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d15775e2496 class=n-a></a>Egerman MA, Glass DJ: Signaling pathways controlling skeletal muscle mass. <i>Crit Rev Biochem Mol Biol.</i> 2014; <b>49</b>(1): 5968. <a target=xrefwindow id=d15775e2504 href="http://www.ncbi.nlm.nih.gov/pubmed/24237131">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2507 href="http://dx.doi.org/10.3109/10409238.2013.857291">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2510 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3913083">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d15775e2519 class=n-a></a>Kon SS, Jones SE, Schofield SJ, <i> et al.</i>: Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study. <i>Thorax.</i> 2015; <b>70</b>(12): 11317. <a target=xrefwindow id=d15775e2530 href="http://www.ncbi.nlm.nih.gov/pubmed/26283709">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2533 href="http://dx.doi.org/10.1136/thoraxjnl-2015-207046">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d15775e2542 class=n-a></a>Sharif R, Parekh TM, Pierson KS, <i> et al.</i>: Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. <i>Ann Am Thorac Soc.</i> 2014; <b>11</b>(5): 68594. <a target=xrefwindow id=d15775e2553 href="http://www.ncbi.nlm.nih.gov/pubmed/24784958">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2556 href="http://dx.doi.org/10.1513/AnnalsATS.201310-358OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4225809">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d15775e2569 class=n-a></a>Oliveira CC, Lee AL, McGinley J, <i> et al.</i>: Falls by individuals with chronic obstructive pulmonary disease: a preliminary 12-month prospective cohort study. <i>Respirology.</i> 2015; <b>20</b>(7): 1096101. <a target=xrefwindow id=d15775e2580 href="http://www.ncbi.nlm.nih.gov/pubmed/26206432">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2583 href="http://dx.doi.org/10.1111/resp.12600">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d15775e2592 class=n-a></a>Lach-Trifilieff E, Minetti GC, Sheppard K, <i> et al.</i>: An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. <i>Mol Cell Biol.</i> 2014; <b>34</b>(4): 60618. <a target=xrefwindow id=d15775e2603 href="http://www.ncbi.nlm.nih.gov/pubmed/24298022">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2606 href="http://dx.doi.org/10.1128/MCB.01307-13">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2610 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3911487">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d15775e2620 class=n-a></a>Bateman ED, Reddel HK, van Zyl-Smit RN, <i> et al.</i>: The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? <i>Lancet Respir Med.</i> 2015; <b>3</b>(9): 71928. <a target=xrefwindow id=d15775e2631 href="http://www.ncbi.nlm.nih.gov/pubmed/26255108">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2634 href="http://dx.doi.org/10.1016/S2213-2600(15)00254-4">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718076747"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2643 class=n-a></a>Vanfleteren LE, Kocks JW, Stone IS, <i> et al.</i>: Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? <i>Thorax.</i> 2014; <b>69</b>(1): 729. <a target=xrefwindow id=d15775e2654 href="http://www.ncbi.nlm.nih.gov/pubmed/23794191">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2657 href="http://dx.doi.org/10.1136/thoraxjnl-2013-203602">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718076747">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d15775e2670 class=n-a></a>Barrecheguren M, Esquinas C, Miravitlles M: The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. <i>Curr Opin Pulm Med.</i> 2015; <b>21</b>(1): 749. <a target=xrefwindow id=d15775e2678 href="http://www.ncbi.nlm.nih.gov/pubmed/25405671">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2681 href="http://dx.doi.org/10.1097/MCP.0000000000000118">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d15775e2690 class=n-a></a>D'Urzo A, Donohue JF, Kardos P, <i> et al.</i>: A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. <i>Expert Opin Pharmacother.</i> 2015; <b>16</b>(12): 184560. <a target=xrefwindow id=d15775e2701 href="http://www.ncbi.nlm.nih.gov/pubmed/26194213">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2704 href="http://dx.doi.org/10.1517/14656566.2015.1067682">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4673525">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d15775e2717 class=n-a></a>Soler X, Ramsdell JW: Are Asthma and COPD a Continuum of the Same Disease? <i>J Allergy Clin Immunol Pract.</i> 2015; <b>3</b>(4): 48995; quiz 4967. <a target=xrefwindow id=d15775e2725 href="http://www.ncbi.nlm.nih.gov/pubmed/26164572">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2728 href="http://dx.doi.org/10.1016/j.jaip.2015.05.030">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d15775e2737 class=n-a></a>Ghebre MA, Bafadhel M, Desai D, <i> et al.</i>: Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease. <i>J Allergy Clin Immunol.</i> 2015; <b>135</b>(1): 6372. <a target=xrefwindow id=d15775e2748 href="http://www.ncbi.nlm.nih.gov/pubmed/25129678">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2751 href="http://dx.doi.org/10.1016/j.jaci.2014.06.035">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4282726">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d15775e2765 class=n-a></a>de Marco R, Marcon A, Rossi A, <i> et al.</i>: Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. <i>Eur Respir J.</i> 2015; <b>46</b>(3): 6719. <a target=xrefwindow id=d15775e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/26113674">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2779 href="http://dx.doi.org/10.1183/09031936.00008615">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d15775e2788 class=n-a></a>Gelb AF, Yamamoto A, Verbeken EK, <i> et al.</i>: Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma With Persistent Expiratory Airflow Limitation. <i>Chest.</i> 2015; <b>148</b>(2): 31320. <a target=xrefwindow id=d15775e2799 href="http://www.ncbi.nlm.nih.gov/pubmed/25950858">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2802 href="http://dx.doi.org/10.1378/chest.14-2483">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d15775e2811 class=n-a></a>Smolonska J, Koppelman GH, Wijmenga C, <i> et al.</i>: Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis. <i>Eur Respir J.</i> 2014; <b>44</b>(4): 86072. <a target=xrefwindow id=d15775e2822 href="http://www.ncbi.nlm.nih.gov/pubmed/24993907">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2825 href="http://dx.doi.org/10.1183/09031936.00001914">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2829 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4217133">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d15775e2838 class=n-a></a>Begh B, Hall IP, Parker SG, <i> et al.</i>: Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. <i>Allergy.</i> 2010; <b>65</b>(4): 47481. <a target=xrefwindow id=d15775e2849 href="http://www.ncbi.nlm.nih.gov/pubmed/19796199">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2852 href="http://dx.doi.org/10.1111/j.1398-9995.2009.02167.x">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725321943"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2861 class=n-a></a>Christenson SA, Steiling K, van den Berge M, <i> et al.</i>: Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2015; <b>191</b>(7): 75866. <a target=xrefwindow id=d15775e2872 href="http://www.ncbi.nlm.nih.gov/pubmed/25611785">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2875 href="http://dx.doi.org/10.1164/rccm.201408-1458OC">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2879 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4407484">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725321943">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718061877"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2892 class=n-a></a>van den Berge M, Steiling K, Timens W, <i> et al.</i>: Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity. <i>Thorax.</i> 2014; <b>69</b>(1): 1423. <a target=xrefwindow id=d15775e2903 href="http://www.ncbi.nlm.nih.gov/pubmed/23925644">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2906 href="http://dx.doi.org/10.1136/thoraxjnl-2012-202878">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2910 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3888587">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718061877">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d15775e2924 class=n-a></a>Hardin M, Cho M, McDonald ML, <i> et al.</i>: The clinical and genetic features of COPD-asthma overlap syndrome. <i>Eur Respir J.</i> 2014; <b>44</b>(2): 34150. <a target=xrefwindow id=d15775e2935 href="http://www.ncbi.nlm.nih.gov/pubmed/24876173">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2938 href="http://dx.doi.org/10.1183/09031936.00216013">Publisher Full Text </a> | <a target=xrefwindow id=d15775e2942 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4154588">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725394081"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15775e2951 class=n-a></a>Kearley J, Silver JS, Sanden C, <i> et al.</i>: Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. <i>Immunity.</i> 2015; <b>42</b>(3): 56679. <a target=xrefwindow id=d15775e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/25786179">PubMed Abstract </a> | <a target=xrefwindow id=d15775e2965 href="http://dx.doi.org/10.1016/j.immuni.2015.02.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725394081">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Sep 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2392/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2392/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Lung Health Research Centre, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia<br/> <sup>2</sup> Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-2392/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Sep 2016, 5:2392 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.7018.1">https://doi.org/10.12688/f1000research.7018.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2016 Anderson GP. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=7556 data-id=7018 data-downloads="" data-views="" data-scholar="10.12688/f1000research.7018.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-2392/v1/pdf?article_uuid=9f38b5e3-4ea1-4c6a-bd52-38a11de677df" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.7018.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Anderson GP. Advances in understanding COPD [version 1; peer review: 3 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2392 (<a href="https://doi.org/10.12688/f1000research.7018.1" target=_blank>https://doi.org/10.12688/f1000research.7018.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=7018 id=mobile-track-article-signin-7018 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/7018?target=/articles/5-2392/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=7556 /> <input name=articleId type=hidden value=7018 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Leonardo M Fabbri</strong>, Respiratory Disease Clinic Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Rob Stockley</strong>, Lung Investigation Unit, University Hospital Birmingham, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Marc Miravitlles</strong>, Department of Pneumology, Vall d'Hebron University Hospital, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Sep 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2392/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2392/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=12192-13412></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=1789-13413></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=6406-13411></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-2392/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Sep 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Leonardo M Fabbri</strong>, Respiratory Disease Clinic Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rob Stockley</strong>, Lung Investigation Unit, University Hospital Birmingham, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Marc Miravitlles</strong>, Department of Pneumology, Vall d'Hebron University Hospital, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-2392/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-2392/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Advances in understanding COPD".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-2392/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-2392/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-2392/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Anderson GP');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-2392/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-2392",
            templates : {
                twitter : "Advances in understanding COPD. Anderson GP, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-2392/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Advances in understanding COPD", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Advances in understanding COPD", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/7018/7556")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "7556");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "13411": 0,
                           "13412": 0,
                           "13413": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "ff03ca7e-d4dc-45ff-b6f5-4d9f8ce112f3";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2392.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2392.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2392.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-2392.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-2392.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>